Skip to main content
Log in

Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The overexpression of Bcl-2, an anti-apoptotic oncogene, identifies human T1 breast cancer patients who have an increased risk of lymph-node metastasis. We examined in these patients (n=142) whether the c-Myc oncogene influences metastatic progression in conjunction or not with Bcl-2 expression and the loss of apoptosis in tumors. The association between Bcl-2 and lymph-node metastasis was only significant when c-Myc was concomitantly expressed (χ2 test, p=0.008). Moreover, very large associations (pOR=6.4) between c-Myc and lymph-node metastasis were observed among Bcl-2 positive tumors and tumors with loss of apoptosis (pOR=8.4). In contrast, the metastatic advantage linked to Bcl-2 was decreased (pOR=2) when c-Myc was not coexpressed. It is concluded that the synergism between Bcl-2 and c-Myc oncogenes may promote metastasis in breast tumors, linked to loss of apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Evan GI, Brown L, Whyte M, Harrington E: Apoptosis and the cell cycle. Curr Opin Cell Biol 7: 825–834, 1995

    Google Scholar 

  2. Packham G, Porter CW, Cleveland JL: c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13: 461–469, 1996

    Google Scholar 

  3. Watson PH, Safneck JR, Le K, Dubik D, Shiu RPC: Relationship of c-Myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902–907, 1993

    Google Scholar 

  4. Nass SJ, Dickson RB: Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44: 1–22, 1997

    Google Scholar 

  5. Thompson EB: The many roles of c-Myc in apoptosis. Annu Rev Physiol 60: 575–600, 1998

    Google Scholar 

  6. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-Myc and Bcl-2 proto-oncogenes. Nature 359: 554–556, 1992

    Google Scholar 

  7. Korsmeyer SJ: Regulators of cell death. Trends in Genet 11: 101–105, 1995

    Google Scholar 

  8. Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci 18: 51–55, 1994

    Google Scholar 

  9. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between Myc and Bcl-2. Nature 348: 331–333, 1990

    Google Scholar 

  10. Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ: The functional basis of c-Myc and Bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res 217: 240–247, 1995

    Google Scholar 

  11. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U: The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph-node-negative breast cancer patients. J Nat Cancer Inst 86: 499–504, 1994

    Google Scholar 

  12. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: Bcl-2 in normal human breast and carcinoma: association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69: 135–139, 1994

    Google Scholar 

  13. Sierra A, Lloveras B, Castellsagué X, Moreno L, Garcia-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60: 54–60, 1995

    Google Scholar 

  14. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237–241, 1995

    Google Scholar 

  15. Sierra A, Castellsagué X, Tórtola S, Escobedo A, Lloveras B, Peinado MA, Moreno A, Fabra A: Apoptosis loss and Bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer. Clin Cancer Res 2: 1887–1894, 1996

    Google Scholar 

  16. Kang Y, Cortina R, Perry RR: Role of c-Myc in tamoxifeninduced apoptosis in estrogen-independent breast cancer cells. J Natl Cancer Inst 88: 279–284, 1996

    Google Scholar 

  17. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ, Giaccia AJ: Modulation of c-Myc activity and apoptosis in vivo. Cancer Res 56: 4315–4319, 1996

    Google Scholar 

  18. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ: Differential regulation of cell cycle characteristics and apoptosis in MMTV-Myc and MMTV-ras mouse mammary tumors. Cancer Res 57: 600–603, 1997

    Google Scholar 

  19. Gibson AW, Cheng T, Johnston RN: Apoptosis induced by c-Myc overexpression is dependent on growth conditions. Exp Cell Res 218: 351–358, 1995

    Google Scholar 

  20. Mooy CM, Luyten GPM, de Jong PTVM, Luider TM, Stijnen T, van de Ham F, van Vroonhoven CCJ, Bosman FT: Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 147: 1097–1104, 1995

    Google Scholar 

  21. Siitonen SM, Kallioniemi O-P, Isola JJ: Proliferating cell nuclear antigen immunohistochemistry using monoclonal 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 142: 1081–1089, 1993

    Google Scholar 

  22. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclearDNAfragmentation. J Cell Biol 119: 493–501, 1992

    Google Scholar 

  23. Breslow NE, Day NE: Statistical methods in cancer research: Volume I – The analysis of case-control studies, (IARC Scientific Publications No. 32), Lyon, International Agency for Research on Cancer, 1980

  24. Baker RJ, Nelder JA: The GLIM system, Release 3. Generalized linear interactive modelling. Numerical Algorithms Group, Oxford, 1978

    Google Scholar 

  25. Sierra A, Castellsagué X, Coll T, Mañas S, Escobedo A, Moreno A, Fabra A: Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas. Int J Cancer 79: 103–110, 1998

    Google Scholar 

  26. Lee YJ, Galoforo SS, Berns CM, Tong WP, Kim HRC, Corry PM: Glucose deprivation-induced cytotoxicity in drug resistant breast carcinoma MCF-7/ADR cells: role of c-Myc and Bcl-2 in apoptotic cell death. J Cell Sci 110: 681–686, 1997

    Google Scholar 

  27. Bouchard C, Staller P, Eilers M: Control of cell proliferation by Myc. Trends Cell Biol 8: 202–206, 1998

    Google Scholar 

  28. Brouillet JP, Theillet C, Maudelonde T, Defrenne A, Simony-Lafontaine J, Sertour J, Pujol H, Jeanteur P, Rochefort H: Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-Myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer 26: 437–441, 1990

    Google Scholar 

  29. Bover L, Barrio M, Bravo AI, Slavutsky I, Larripa I, Bolondi A, Ayala M, Mordoh J: The human breast cancer cell line IIB-BR-G has amplified c-Myc and c-Fos oncogenes in vitro and is spontaneously metastatic in vivo. Cell Mol Biol 44: 493–504, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sierra, A., Castellsague, X., Escobedo, A. et al. Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas. Breast Cancer Res Treat 54, 39–45 (1999). https://doi.org/10.1023/A:1006120006471

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006120006471

Navigation